News
LAB
1.420
-5.96%
-0.090
Weekly Report: what happened at LAB last week (0127-0131)?
Weekly Report · 3d ago
Weekly Report: what happened at LAB last week (0120-0124)?
Weekly Report · 01/27 09:17
Weekly Report: what happened at LAB last week (0113-0117)?
Weekly Report · 01/20 09:16
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
TipRanks · 01/17 20:35
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength?
NASDAQ · 01/14 11:08
Standard BioTools Up 28%, on Pace for Largest Percent Increase Since May 2022 -- Data Talk
Dow Jones · 01/13 17:56
J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
TipRanks · 01/13 17:10
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Benzinga · 01/13 15:57
Standard BioTools Reports 2024 Revenue Achievements and Plans
TipRanks · 01/13 13:14
Standard BioTools reports preliminary Q4 revenue $46.5M, consensus $43.03M
TipRanks · 01/13 12:11
*Standard BioTools Sees 2024 Rev $174M >LAB
Dow Jones · 01/13 12:08
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$52m market cap drop, institutional owners may be forced to take severe actions
Simply Wall St · 01/13 12:04
STANDARD BIOTOOLS INC: EXPECTS FULL YEAR 2024 REVENUE OF APPROXIMATELY $174 MLN
Reuters · 01/13 12:00
Press Release: Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Dow Jones · 01/13 12:00
Illumina launches pilot proteomics program with UK Biobank, collaborators
TipRanks · 01/13 10:30
Weekly Report: what happened at LAB last week (0106-0110)?
Weekly Report · 01/13 09:16
Standard BioTools Announces CCO Jeremy Davis’s Departure
TipRanks · 01/10 21:36
Standard BioTools announces publication on study using SomaScan Platform
TipRanks · 01/08 12:11
Weekly Report: what happened at LAB last week (1230-0103)?
Weekly Report · 01/06 09:17
Weekly Report: what happened at LAB last week (1223-1227)?
Weekly Report · 12/30/2024 09:16
More
Webull provides a variety of real-time LAB stock news. You can receive the latest news about STANDARD BIOTOOLS INC through multiple platforms. This information may help you make smarter investment decisions.
About LAB
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.